International Flavors & Fragrances Inc. (VIE:IFF)
Austria · Delayed Price · Currency is EUR | Market Cap | 18.46B +32.2% |
| Revenue (ttm) | 9.44B +11.5% |
| Net Income | 242.46M |
| EPS | 0.95 |
| Shares Out | n/a |
| PE Ratio | 76.13 |
| Forward PE | 26.09 |
| Dividend | 1.38 (1.89%) |
| Ex-Dividend Date | Sep 18, 2026 |
| Volume | n/a |
| Open | 73.98 |
| Previous Close | 73.21 |
| Day's Range | 72.84 - 73.98 |
| 52-Week Range | 51.60 - 76.46 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 5, 2026 |
About VIE:IFF
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, and complementary adjacent products in the United States, and internationally. It operates in through Taste, Food Ingredients, Health & Biosciences, and Scent segments. The Taste segment offers savory products such as soups, sauces, meat, fish, poultry, snacks; beverages consists of juice drinks, carbonated or flavored beverages, spirits; sweets comprising, bakery products, candy, cereal, chewing gum; ... [Read more]
News
IFF launches Omni-Bos PHY phytase enzyme
IFF (IFF) announced the launch of Omni-Bos PHY, a novel phytase enzyme designed specifically for dairy cattle. The technology helps producers improve nutrient utilization and feed efficiency by unlock...
IFF Launches Omni-Bos™ PHY to Help Dairy Producers Get More Value from Feed
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances and health and biosciences — today announced the launch of Omni-Bos™ PHY, a novel phytase enzyme designed specifical...
IFF initiated with a Sector Weight at KeyBanc
KeyBanc initiated coverage of IFF (IFF) with a Sector Weight rating and no price target The firm rolled out coverage on 19 chemical and agriculture companies, with nine Overweights, nine…
IFF initiated with a Sector Weight at KeyBanc
KeyBanc initiated coverage of IFF (IFF) with a Sector Weight rating.
International Flavors & Fragrances Transcript: Barclays 19th Annual Global Consumer Conference
The organization has transformed into three focused, innovation-driven businesses, improving financial health, talent retention, and operational discipline. Growth is driven by enhanced R&D, automation, and a balanced customer mix, with further gains expected as capacity investments and strategic divestitures are completed.
India investigates fragrance giants over price collusion, document shows
Global fragrance makers Givaudan , Firmenich and International Flavors & Fragrances face a second antitrust investigation by Indian authorities, according to a regulatory document seen by Reuters.
IFF Report Finds GLP-1 Is Reshaping Food Choices and Eating Behaviors Among Indian Consumers
NEW DELHI--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances and health and biosciences — released new research examining how GLP-1 use is influencing food behaviors among Indi...
IFF to Webcast Fireside Chat at Barclays Global Consumer Conference on Sept. 10
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) today announced that Chief Executive Officer Erik Fyrwald will participate in a fireside chat at the Barclays Global Consumer Conference on Thursday...
IFF price target raised to $96 from $90 at Barclays
Barclays raised the firm’s price target on IFF (IFF) to $96 from $90 and keeps an Overweight rating on the shares. The company’s sales growth accelerated in Q2, and it…
IFF price target raised to $100 from $95 at Morgan Stanley
Morgan Stanley analyst Lisa De Neve raised the firm’s price target on IFF (IFF) to $100 from $95 and keeps an Overweight rating on the shares. IFF continues to screen…
IFF price target raised to $100 from $90 at Baird
Baird analyst Ghansham Panjabi raised the firm’s price target on IFF (IFF) to $100 from $90 and keeps an Outperform rating on the shares.
IFF price target raised to $91 from $84 at UBS
UBS analyst Joshua Spector raised the firm’s price target on IFF (IFF) to $91 from $84 and keeps a Neutral rating on the shares.
IFF downgraded to Hold from Buy at Vertical Research
Vertical Research downgraded IFF (IFF) to Hold from Buy with a $93 price target
IFF price target raised to $95 from $90 at Oppenheimer
Oppenheimer raised the firm’s price target on IFF (IFF) to $95 from $90 and keeps an Outperform rating on the shares. The firm notes IFF shares closed up 8.9% on…
IFF price target raised to $105 from $100 at Benchmark
Benchmark raised the firm’s price target on IFF (IFF) to $105 from $100 and keeps a Buy rating on the shares.
IFF price target raised to $101 from $88 at Citi
Citi raised the firm’s price target on IFF (IFF) to $101 from $88 and keeps a Buy rating on the shares post the earnings report. The company is seeing resilient…
International Flavors & Fragrances Earnings Call Transcript: Q2 2026
Strong Q2 2026 results featured 6% revenue and 8% EBITDA growth, driven by volume and productivity gains. The Food Ingredients divestiture sharpens focus on core segments, with proceeds allocated to debt reduction and a $2.5B share repurchase. Margin expansion is expected as stranded costs are eliminated.
International Flavors & Fragrances Earnings release: Q2 2026
International Flavors & Fragrances released its Q2 2026 earnings on August 5, 2026, summarizing the period's financial results.
International Flavors & Fragrances Quarterly report: Q2 2026
International Flavors & Fragrances has published its Q2 2026 quarterly earnings report on August 5, 2026.
International Flavors & Fragrances Slides: Q2 2026
International Flavors & Fragrances has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 5, 2026.
IFF reports Q2 adjusted EPS 57c, consensus $1.12
Reports Q2 revenue $1.954B, consensus $2.69B. “IFF (IFF) delivered a strong first half of 2026 on a continuing operations basis,” said Erik Fyrwald, CEO of IFF. “Performance was driven by…
IFF Reports Second Quarter 2026 Results; Announces Use of Proceeds Plan for Food Ingredients Divestiture
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) reported financial results for the second quarter ended June 30, 2026. Results are presented on a continuing operations basis, excluding the Food In...
IFF Declares Dividend for Third Quarter 2026
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on October 9, 2...
SuanNutra, a Carbyne Equity Partners Portfolio Company, Expands Product Portfolio with Specialty Natural Ingredients Businesses from IFF
MADRID, July 20, 2026 /PRNewswire/ -- SuanNutra, a global provider of science-backed branded and functional ingredients, and Carbyne Equity Partners today announced that SuanNutra has signed an agreem...
IFF to sell portfolio of botanical extracts, vitamins and minerals to SuanNutra
IFF (IFF) announced that it has entered into an agreement with SuanNutra, a Carbyne Equity Partners portfolio company and global provider of science-backed branded and functional ingredients, to sell ...